This article is part of the supplement: 24th International Symposium on Intensive Care and Emergency Medicine
Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
Critical Care 2004, 8(Suppl 1):P89 doi:10.1186/cc2556
Accesses
- Last 30 days: 35 accesses
- Last 365 days: 169 accesses
- All time: 1330 accesses